Prestige Consumer Healthcare (PBH) Receivables (2011 - 2025)

Prestige Consumer Healthcare's Receivables history runs 15 years deep, the most recent figure standing at $190.5 million for Q4 2025.

• On a quarterly basis, Receivables rose 13.86% year-over-year to $190.5 million in Q4 2025; TTM through Dec 2025 was $190.5 million, a 13.86% increase from a year earlier, with the FY2025 full-year figure at $194.3 million, up 9.91% from the prior year.
• Receivables retreated to $190.5 million in Q4 2025 per PBH's latest filing, from $199.0 million in the prior quarter.
• Across five years, Receivables topped out at $199.0 million in Q3 2025 and bottomed at $114.7 million in Q1 2021.
• The 5-year median for Receivables is $161.0 million (2023), against an average of $160.1 million.
• Across the five-year window, Receivables dropped 23.82% in 2021 and grew 21.68% in 2025, its largest moves.
• Year by year, Receivables stood at $134.3 million in 2021, then grew by 17.0% to $157.1 million in 2022, then grew by 10.95% to $174.3 million in 2023, then declined by 4.02% to $167.3 million in 2024, then advanced by 13.86% to $190.5 million in 2025.
• Per Business Quant, the three latest PBH Receivables figures stand at $190.5 million (Q4 2025), $199.0 million (Q3 2025), and $168.4 million (Q2 2025).